Cover Image

HARDBACK
$52.95



View/Hide Left Panel

TABLE A2–1 Incidence of Chlamydia in Men and Women

Age Groups

Male Population

Incidence Rates (per 100,000)

Cases

<1

2,030,000

0.00

0

1–4

8,314,000

120.28

10,000

5–14

19,502,000

461.49

90,000

15–24

18,516,000

6,480.88

1,200,000

25–34

20,835,000

2,879.77

600,000

35–44

20,911,000

334.75

70,000

45–54

14,777,000

135.35

20,000

55–64

10,101,000

99.00

10,000

65–74

8,420,000

0.00

0

75–84

4,274,000

0.00

0

≥85

1,005,000

0.00

0

Total

128,685,000

1,554.18

2,000,000

Age Groups

Female Population

Incidence Rates (per 100,000)

Cases

<1

1,933,000

0.00

0

1–4

7,905,000

126.50

10,000

5–14

18,554,000

485.07

90,000

15–24

17,747,000

6,761.71

1,200,000

25–34

20,835,000

2,879.77

600,000

35–44

21,238,000

329.60

70,000

45–54

15,447,000

129.47

20,000

55–64

11,140,000

89.77

10,000

65–74

10,544,000

0.00

0

75–84

6,814,000

0.00

0

85+

2,593,000

0.00

0

Total

134,750,000

1,484.23

2,000,000

Health consequences of chlamydia infection in women accounted for in the model include acute urethral syndrome, mild cervicitis, pelvic inflammatory disease (PID) and its sequelae (ectopic pregnancy, chronic pelvic pain, and infertility, assumed for calculation purposes to incur costs and decreased health states with a 5-year lag from infection), Reiter’s syndrome, and arthritis. Table A2–2 illustrates the estimated number of cases in each state, the duration of time that state is experienced, and the health utility index (HUI) associated with each state. These vary greatly. At one end of the spectrum are a large number of relatively minor conditions such as acute urethral syndrome (100,000 cases experiencing three days of an HUI of .75). At the other end are many fewer



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement